KRAS mutations were detected in 38 out of 86 (44.2%) colon cancer samples (Table 2, Figure 2A), of which 28 (73.7%) samples had mutations in codon 12 and 10 (26.3%) samples had mutations in codon 13 (Table 3). This evidence concerns the gene KRAS and malignant colon neoplasm.